31 May 2024
31 May 2024
With the completed acquisition, Sanofi will gain access to SAR447537, Inhibrx’s human recombinant protein in development for AATD.
The speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can be achieved in fighting infectious diseases. From collaborative digital platforms to utilizing AI, GlobalData examines some of the key trends affecting contract research organizations (CROs).
The approval is based on results from the MCL cohort of the TRANSCEND NHL 001 trial.
The bill aims to prevent US companies from working with Chinese biotechs.
The approval is based on the totality of evidence, including clinical findings from the Phase III VALOR study.
Royalty Pharma will receive 15% on US sales of vorasidenib, up to $1bn, and at a 12% rate beyond that.
Several personalities, including a Nobel-winning scientist who helped discover HIV, have written to Gilead in an open letter about fairer access to Sunlenca.
The company has fired 53% of its workforce and is shutting down the development of a Phase I pipeline candidate.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
